ANDA 220413, held by Dr. Reddy's Laboratories. Fexofenadine Hydrochloride.
As of Nov 21, 2026, ANDA 220413 (Fexofenadine Hydrochloride), held by Dr. Reddy's Laboratories, was first approved by FDA on Jul 30, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 30, 2026 | Original application | Approved | None posted |
| Fexofenadine Hydrochloride60MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters